Literature DB >> 17998021

Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.

Yuki Kita1, Eishiro Mizukoshi, Toshinari Takamura, Masaru Sakurai, Yoshiko Takata, Kuniaki Arai, Tatsuya Yamashita, Yasunari Nakamoto, Shuichi Kaneko.   

Abstract

Diabetes is a risk factor for the progression of liver fibrosis and development of hepatocellular carcinoma in chronic hepatitis C. However, the impact of diabetes on the long-term prognosis and the synergistic interactions of various host factors for diabetes to the progression of liver fibrosis are unknown. In the present study, we examined the host factors associated with the progression of hepatitis C in 68 patients with a posttransfusion hepatitis (PTH) and analyzed the relationships. Multivariate analysis showed that age of PTH, being male, and type 2 diabetes mellitus were risk factors for the progression of liver fibrosis. By the Kaplan-Meier method, the cirrhosis-free survival rates after the onset of PTH were significantly lower in the diabetic group than in the nondiabetic group (P < .01). Diabetes also had a great impact on the long-term prognosis of chronic hepatitis C by reducing the time from PTH to the occurrence of hepatocellular carcinoma (P < .01) and to liver-related death (P < .05). Coexistence of obesity (body mass index > or =25 kg/m(2)) or hypertriglyceridemia (> or =150 mg/dL) with diabetes had a synergistic effect on liver fibrosis progression in patients with chronic hepatitis C. Thus, the treatment of diabetes, obesity, and hypertriglyceridemia may hold the key to improving the prognosis of chronic hepatitis.

Entities:  

Mesh:

Year:  2007        PMID: 17998021     DOI: 10.1016/j.metabol.2007.07.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  Hepatitis C virus and insulin resistance/diabetes mellitus.

Authors:  Dawn M Torres; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

Review 2.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

3.  Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension.

Authors:  Maya Balakrishnan; Guadalupe Garcia-Tsao; Yanghong Deng; Maria Ciarleglio; Dhanpat Jain
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

4.  Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature.

Authors:  Silvia Fabiani; Poupak Fallahi; Silvia Martina Ferrari; Mario Miccoli; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

5.  Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.

Authors:  Mohammed J Saeed; Margaret A Olsen; William G Powderly; Rachel M Presti
Journal:  J Clin Gastroenterol       Date:  2017-01       Impact factor: 3.062

6.  Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.

Authors:  Stephen E Livingston; Heike Deubner; Dana L Bruden; Brian J McMahon; Chriss E Homan; Lisa J Townshend-Bulson; Michael G Bruce; Thomas W Hennessy; James L Williams; David R Gretch
Journal:  Can J Gastroenterol       Date:  2010-07       Impact factor: 3.522

Review 7.  Hepatitis C virus and type 2 diabetes.

Authors:  Francesco Negro; Mahnaz Alaei
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

8.  Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.

Authors:  Qing-Lei Zeng; Guo-Hua Feng; Ji-Yuan Zhang; Yan Chen; Bin Yang; Hui-Huang Huang; Xue-Xiu Zhang; Zheng Zhang; Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

9.  The impact of host factors on management of hepatitis C virus.

Authors:  Mahmoud Aboelneen Khattab; Mohammed Eslam
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

10.  Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis.

Authors:  Erika Hamaguchi; Toshinari Takamura; Masaru Sakurai; Eishiro Mizukoshi; Yoh Zen; Yumie Takeshita; Seiichiro Kurita; Kuniaki Arai; Tatsuya Yamashita; Motoko Sasaki; Yasuni Nakanuma; Shuichi Kaneko
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.